EBOS Group (EBOSF) Stock Price, News & Analysis

Company Overview

EBOS Group (OTCMKTS:EBOSF) is a leading distributor of healthcare and animal care products and services in Australia and New Zealand. The company operates through two primary divisions: Healthcare, which supplies pharmaceuticals, medical consumables, diagnostic and surgical equipment to hospitals, pharmacies and aged‐care facilities; and Animal Care, which provides veterinary medicines, nutrition and equipment to veterinary clinics, farmers and pet specialty outlets.

In its Healthcare division, EBOS Group offers a comprehensive range of prescription and over‐the‐counter medicines, medical devices and consumer health products. The business supports retail pharmacy networks, hospital supply chains and allied health professionals with value‐added services such as procurement, logistics, product training and regulatory support. Through Animal Care, the company distributes a portfolio of veterinary pharmaceuticals, vaccines, diagnostics and nutrition products, alongside equipment and consumables for livestock and companion animals.

Tracing its roots to a small pharmaceuticals wholesaler established in the early 1920s in New Zealand, EBOS Group has grown through a series of strategic acquisitions and organic expansions. The company is headquartered in the Australia–New Zealand region and maintains an extensive network of distribution centres, warehousing facilities and service locations across both countries. This regional footprint enables EBOS to deliver timely logistics and local support to its diverse customer base.

EBOS Group is governed by an experienced board of directors and led by an executive management team with deep expertise in healthcare distribution and animal health. The company continues to pursue growth opportunities through selective acquisitions, infrastructure investment and the development of value‐added solutions aimed at enhancing supply chain efficiency and customer outcomes.

Key Stats

• Today's Range: $23.75 to $23.75
• 50-Day Range: $23.75 to $23.75
• 52-Week Range: $20.02 to $23.75
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

EBOSF Stock Analysis - Frequently Asked Questions

How have EBOSF shares performed this year?

EBOS Group's stock was trading at $20.02 at the beginning of 2025. Since then, EBOSF stock has increased by 18.6% and is now trading at $23.75.

How do I buy shares of EBOS Group?

Shares of EBOSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Distribution
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:EBOSF
• CIK: 1533082
• Web: www.ebosgroup.com
• Phone: 61-3-9918-5555
• Fax: N/A
• Employees: 5,000
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A